Clinical Trial Update: To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the efficacy and safety of ADVAGRAF after prior tacrolimus treatment in new liver transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: Linical Korea | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED